Discover
LIXT
Lixte Biotechnology Holdings, Inc.
7.67
1 x 8.02
1 x 7.74
bid
ask
+
0.25
3.37%
1 @ 04:00 PM
7.97 +0.30 (3.91%)
| Ytd | 95.17% | |
| 1y | 550.00% |
7.00
day range
8.38
1.28
52 week range
8.38
| Open | 7.42 | Prev Close | 7.42 | Low | 7.00 | High | 8.38 | Mkt Cap | 133.35M |
| Vol | 1.86M | Avg Vol | 225.88K | EPS | -1.15 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.17 | Short Ratio | 0.31 | Inst. Own | 9.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 5.75 | 200-d Avg | 4.30 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.99M | ||
| Research and Development Expense | 333.38K | ||
| Selling, General and Administrative Expense | 1.65M | ||
| Operating Income | -1.99M | ||
| Interest Expense | 3.10K | ||
| Net Income | -1.92M | ||
| Net Income Common Stock | -1.94M | ||
| Net Income Common Stock (USD) | -1.94M | ||
| Consolidated Income | -1.99M | ||
| Net Income to Non-Controlling Interests | -63.93K | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -1.92M | ||
| Earning Before Interest & Taxes (USD) | -1.92M | ||
| Preferred Dividends Income Statement Impact | 17.88K | ||
| Weighted Average Shares | 10.89M | ||
| Weighted Average Shares Diluted | 10.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.25M | ||
| Cash and Equivalents (USD) | 3.25M | ||
| Current Assets | 3.41M | ||
| Property, Plant & Equipment Net | 7.46M | ||
| Total Assets | 10.87M | ||
| Debt Current | 595.42K | ||
| Total Debt | 1.06M | ||
| Current Liabilities | 1.22M | ||
| Debt Non-Current | 461.77K | ||
| Total Liabilities | 1.69M | ||
| Accumulated Retained Earnings (Deficit) | -60.00M | ||
| Shareholders Equity | 7.95M | ||
| Shareholders Equity (USD) | 7.95M | ||
| Assets Non-Current | 7.46M | ||
| Total Debt (USD) | 1.06M | ||
| Liabilities Non-Current | 461.77K | ||
| Trade and Non-Trade Payables | 391.08K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 122.55K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.86M | ||
| Capital Expenditure | -24.86K | ||
| Net Cash Flow from Investing | -24.86K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.86M | ||
| Net Cash Flow from Operations | -1.83M | ||
| Share Based Compensation | 82.18K | ||